Condition
Cancer Childhood
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Recruiting1
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07201038RecruitingPrimary
Ultrafast Whole Genome Sequencing for Childhood Cancer
NCT03472807Not ApplicableTerminated
EXOme Rare Cancers in Children (EXOCARE)
NCT05584930Not ApplicableCompletedPrimary
Clusterin, Ptx3 and Pediatric Febrile Neutropenia (CluPPFeN)
NCT05202925Not ApplicableCompletedPrimary
Musical Training Programme to Improve Neurocognitive Functioning of Children Surviving Brain Tumours
NCT03544190CompletedPrimary
Psychometric Evaluation of the Chinese Version of the Resilience Scale-10 for Cancer Children
Showing all 5 trials